FDA Inspection 945450 — Sunshine Lake Pharma Co., Ltd

Sunshine Lake Pharma Co., Ltd — FEI 3007721552

The FDA completed an inspection of Sunshine Lake Pharma Co., Ltd on September 25, 2015 in Dongguan. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 25, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dongguan (China)